Scheme 6. CM-Based Approach to the Pyrrole Subunit of Atorvastatin
synthesis of 2,4-disubstituted pyrroles (as in 5f). Finally, as
the regiochemistry of the final target is dictated by the nature
of the aminoenone precursor, programmable access to various
different substitution patterns is readily achieved (cf. alkyl/
aryl substitution in 5g and 5h).
Sc(OTf)3-promoted Friedel-Crafts type acylation with
phenylisocyanate to deliver the key tetrasubstituted pyrrole
subunit 11 in good yield; the structure of 11 was confirmed
by X-ray crystallography (see Supporting Informa-
tion).17,18
The direct formation of pyrroles from the Heck step is
most likely due to mechanistic requirements that were
delineated previously in our furan studies.1 Carbopalladation
(syn) of the enone moiety is followed by ꢀ-hydride elimina-
tion (syn), and these processes should enforce trans to cis
isomerization of the alkene. The resulting adduct is then
perfectly set up for in situ aminal formation and dehydration
to the target pyrrole (see Scheme 1, bottom).14
The relatively high reactivity of the pyrrole nucleus
detracts from applications of this substructure in medicinal
chemistry. However, this belies the value of highly substi-
tuted derivatives where reactivity is often attenuated. Indeed,
such polysubstituted pyrroles have potentially profound
medicinal impact, as evidenced by Atorvastatin 12 (Lipitor),
the world’s largest selling pharmaceutical (Scheme 6).15 This
compound provides a suitable testbed for our CM-based
synthetic methodology and also acts as a vehicle to demon-
strate that tetrasubstituted pyrroles are available via C-H
functionalization of the trisubstituted variants reported
here. Accordingly, conversion of aldehyde 6 to allylic
amine derivative 7 was readily achieved via the corre-
sponding sulfone.6 Next, CM of 7 with enone 816 delivered
aminoenone 9 in 50% yield. Heck reaction of this species
(with bromobenzene) was demanding (cf. pyrrole 5g), but
after optimization, pyrrole 10 was generated in 56% yield.
Hydrolytic Cbz deprotection (KOH) was followed by
In summary, olefin CM provides an efficient and general
entry to trans-γ-aminoenones which then function as versatile
precursors to mono-, di-, and trisubstituted pyrrole deriva-
tives. Tetrasubstituted variants are accessible via function-
alization of the remaining pyrrole C-H bond, as demon-
strated by a synthesis of the core of Atorvastatin. The
methodologies presented here combine readily available
precursors in a direct, convergent, and regiocontrolled manner
to provide a powerful entry to polysubstituted pyrroles.
Acknowledgment. We thank the EPSRC for financial
support and the Oxford Chemical Crystallography Service
for use of instrumentation.
Supporting Information Available: Copies of 1H and 13C
NMR spectra and experimental procedures are available. This
material is available free of charge via the Internet at
OL101681R
(17) The synthesis of pyrrole 11 has been reported previously: Pandey,
P. S.; Rao, T. S. Bioorg. Med. Chem. Lett. 2004, 14, 129–131. However,
the 13C NMR data obtained for our material are not consistent with that
reported earlier. For this reason structural confirmation of 11 was undertaken
by X-ray crystallography. This, in conjunction with 2D NMR and nOe data,
also underpins the structural assignment of the other pyrroles presented in
this paper (see Supporting Information).
(18) Selective (but low yielding; < 20%) N-alkylation of 11 with 2-(2-
bromoethyl)-1,3-dioxolane (see Supporting Information) affords an inter-
mediate which has been converted previously to 12 in 4 steps: Roth, B. D.;
Blankley, C. J.; Chucholowski, A. W.; Ferguson, E.; Hoefle, M. L.; Ortwine,
D. F.; Newton, R. S.; Sekerke, C. S.; Sliskovic, D. R.; Stratton, C. D.;
Wilson, M. W. J. Med. Chem. 1991, 34, 357–366. We are currently
investigating strategies for the efficient and direct installation of a fully
functionalized side chain.
(14) For a related aminal dehydration to afford a pyrrole, see: Mori,
M.; Hashimoto, A.; Shibasaki, M. J. Org. Chem. 1993, 58, 6503–6504.
(15) Roth, B. D. US Patent 5,273,995.
(16) Fujieda, S.; Tomita, M.; Fuhshuku, K.-i.; Ohba, S.; Nishiyama, S.;
Sugai, T. AdV. Synth. Catal. 2005, 347, 1099–1109.
Org. Lett., Vol. 12, No. 18, 2010
4097